+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Novo Nordisk A/S - logo

Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. Key products include diabetes care medications and devices. Novo Nordisk is also involved with hemostasis management, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 40,000 employees in 75 countries, and markets its products in more than 180 countries.

The Medication Compliance Monitoring Market - 1st Edition - Product Thumbnail Image

The Medication Compliance Monitoring Market - 1st Edition

  • Report
  • October 2023
  • 120 Pages
  • Global
From
Bleeding Disorders Treatment Market - Global Forecast 2025-2032 - Product Thumbnail Image

Bleeding Disorders Treatment Market - Global Forecast 2025-2032

  • Report
  • November 2025
  • 190 Pages
  • Global
From
From
From
Menopause Market Report 2023-2033 - Product Thumbnail Image

Menopause Market Report 2023-2033

  • Report
  • May 2023
  • 253 Pages
  • Global
From
Menopause Market - Global Strategic Business Report - Product Thumbnail Image

Menopause Market - Global Strategic Business Report

  • Report
  • December 2025
  • 181 Pages
  • Global
From
Bio-Pharma Market 2025-2029 - Product Thumbnail Image

Bio-Pharma Market 2025-2029

  • Report
  • June 2025
  • 229 Pages
  • Global
From
From
From
Oral Proteins & Peptides Market - Global Forecast 2025-2032 - Product Thumbnail Image

Oral Proteins & Peptides Market - Global Forecast 2025-2032

  • Report
  • November 2025
  • 190 Pages
  • Global
From
From
Chronic Lymphocytic Leukemia Treatment Market Report 2025 - Product Thumbnail Image

Chronic Lymphocytic Leukemia Treatment Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Crohn`s Disease (CD) Therapy - Global Strategic Business Report - Product Thumbnail Image

Crohn`s Disease (CD) Therapy - Global Strategic Business Report

  • Report
  • December 2025
  • 142 Pages
  • Global
From
Moderate And Severe Chronic Kidney Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Moderate And Severe Chronic Kidney Disease - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
From
Loading Indicator